Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions

International Journal of Pharmaceutics

Volumn 431, Issue 1-2, 2012, Pages 101-110

  Kanthamneni, Naveen ^a   Sharma, Sadhana ^a   Meenach, Samantha A ^a   Billet, Beau ^b   Zhao, Ji Cheng ^b   Bachelder, Eric M ^a   Ainslie, Kristy M ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b The Ohio State University   (United States)

^c NONE   (United States)

Author keywords

Acid sensitive polymer; Horseradish peroxidase; Microparticle; Storage; Vaccines

Indexed keywords

ACETALATED DEXTRAN; DEXTRAN; HORSERADISH PEROXIDASE; POLYGLACTIN; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; ENZYME ACTIVITY; ENZYME STABILITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STORAGE TEMPERATURE; ULTRASOUND;

DEXTRANS; DRUG CARRIERS; DRUG STABILITY; DRUG STORAGE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; NANOPARTICLES; TEMPERATURE; VACCINES;

EID: 84861338462     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.043     Document Type: Article

References (33)

1. J.P. Amorij, A. Huckriede, J. Wilschut, H.W. Frijlink, and W.L. Hinrichs Development of stable influenza vaccine powder formulations: challenges and possibilities Pharm. Res. 25 2008 1256 1273
2. E.M. Bachelder, T.T. Beaudette, K.E. Broaders, J. Dashe, and J.M. Frechet Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications J. Am. Chem. Soc. 130 2008 10494 10495
3. E.M. Bachelder, T.T. Beaudette, K.E. Broaders, J.M. Frechet, M.T. Albrecht, A.J. Mateczun, K.M. Ainslie, J.T. Pesce, and A.M. Keane-Myers In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants Mol. Pharm. 7 2010 826 835
4. K.E. Broaders, J.A. Cohen, T.T. Beaudette, E.M. Bachelder, and J.M. Frechet Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy Proc. Natl. Acad. Sci. U.S.A. 106 2009 5497 5502
5. J.F. Carpenter, M.J. Pikal, B.S. Chang, and T.W. Randolph Rational design of stable lyophilized protein formulations: some practical advice Pharm. Res. 14 1997 969 975
6. K.G. Carrasquillo, H.R. Costantino, R.A. Cordero, C.C. Hsu, and K. Griebenow On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer J. Pharm. Sci. 88 1999 166 173
7. J. Coleman, and A. Lowman Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties J. Biomater. Sci. Polym. Ed. 2011 (Epub ahead of print)
8. D. Chen, and D. Kristensen Opportunities and challenges of developing thermostable vaccines Expert Rev. Vaccines 8 2009 547 557
9. G.T. Hermanson Bioconjugate Techniques 1996 Academic Press San Diego
10. S.W. Howland, and K.D. Wittrup Antigen release kinetics in the phagosome are critical to cross-presentation efficiency J. Immunol. 180 2008 1576 1583
11. Kauffman, K.J., Kanthamneni, N., Meenach, S.A., Pierson, B.C., Bachelder, E.M., Ainslie, K.M., 2011. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression, Int. J. Pharm., in press.
12. G.C. Le Goff, L.J. Blum, and C.A. Marquette Enhanced colorimetric detection on porous microarrays using in situ substrate production Anal. Chem. 83 2011 3610 3615
13. S. Li, J. Hu, and B. Liu Use of chemically modified PMMA microspheres for enzyme immobilization Biosystems 77 2004 25 32
14. A.S. Lauring, and J.O. Jones Rationalizing the development of live attenuated virus vaccines Nat. Biotechnol. 28 2010 573 579
15. L. Lu, S.J. Peter, M.D. Lyman, H.L. Lai, S.M. Leite, J.A. Tamada, S. Uyama, J.P. Vacanti, R. Langer, and A.G. Mikos In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams Biomaterials 21 2000 1837 1845
16. V. Manolova, A. Flace, A. Bauer, M. Schwarz, K. Saudan, and P.M.F. Bachmann Nanoparticles target distinct dendritic cell populations according to their size Eur. J. Immunol. 38 2008 1404 1413
17. D.M. Matthias, J. Robertson, M.M. Garrison, S. Newland, and C. Nelson Freezing temperatures in the vaccine cold chain: a systematic literature review Vaccine 25 2007 3980 3986
18. D. Mohanan, B. Gander, T.M. Kundig, and P. Johansen Encapsulation of antigen in poly(d,l-lactide-co-glycolide) microspheres protects from harmful effects of gamma-irradiation as assessed in mice Eur. J. Pharm. Biopharm. 2011
19. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
20. M. Naessens, A. Cerdobbel, W. Soetaert, and E.J. Vandamme Leuconostoc dextransucrase and dextran: production, properties and applications J. Chem. Technol. Biotechnol. 80 2005 845 860
21. Y. Perrie, A.R. Mohammed, D.J. Kirby, S.E. McNeil, and V.W. Bramwell Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens Int. J. Pharm. 364 2008 272 280
22. A.C. Rice-Ficht, A.M. Arenas-Gamboa, M.M. Kahl-McDonagh, and T.A. Ficht Polymeric particles in vaccine delivery Curr. Opin. Microbiol. 13 2010 106 112
23. B. Rogers, K. Dennison, N. Adepoju, S. Dowd, and K. Uedoi Vaccine cold chain: part 1. Proper handling and storage of vaccine AAOHN J. 58 2010 334 337 quiz 345-336
24. J.J. Rouse, F. Mohamed, and C.F. van der Walle Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA Int. J. Pharm. 339 2007 112 120
25. R.A. Silva, A.M. Carmona-Ribeiro, and D.F. Petri Adsorption behavior and activity of horseradish peroxidase onto polysaccharide-decorated particles Int. J. Biol. Macromol. 41 2007 404 409
26. L. Singh, V. Kumar, and B.D. Ratner Generation of porous microcellular 85/15 poly (dl-lactide-co-glycolide) foams for biomedical applications Biomaterials 25 2004 2611 2617
27. M. Singh, A. Chakrapani, and D. O'Hagan Nanoparticles and microparticles as vaccine-delivery systems Expert Rev. Vaccines 6 2007 797 808
28. B.R. Sloat, M.A. Sandoval, and Z. Cui Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain Int. J. Pharm. 393 2010 197 202
29. C.M. Solbrig, J.K. Saucier-Sawyer, V. Cody, W.M. Saltzman, and D.J. Hanlon Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells Mol. Pharm. 4 2007 47 57
30. Z. Temocin, and M. Yigitoglu Studies on the activity and stability of immobilized horseradish peroxidase on poly(ethylene terephthalate) grafted acrylamide fiber Bioprocess Biosyst. Eng. 32 2009 467 474
31. T. Wirkas, S. Toikilik, N. Miller, C. Morgan, and C.J. Clements A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries Vaccine 25 2007 691 697
32. Y.Y. Yang, H.H. Chia, and T.S. Chung Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method J. Control. Release 69 2000 81 96
33. Y.Y. Yang, T.S. Chung, and N.P. Ng Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method Biomaterials 22 2001 231 241